Moving Toward the Outpatient DIEP Flap: Factors Influencing Early Discharge.

Plastic and reconstructive surgery 2025 Vol.156(2) p. 162e-171e

Graziano FD, Plotsker EL, Amakiri UO, Shammas RL, Vingan PS, Mehrara BJ, Stern CS, Nelson JA, Matros E, Allen RJ

관련 도메인

Abstract

[BACKGROUND] Enhanced recovery after surgery (ERAS) protocols can reduce the length of stay (LOS) for surgical patients, including those undergoing unilateral deep inferior epigastric artery perforator (DIEP) flap breast reconstruction, allowing most patients to be discharged by postoperative day 2. However, some patients require a prolonged inpatient stay because of difficulty completing postoperative milestones. This study aims to identify factors associated with increased LOS after DIEP flap breast reconstruction and to assess safety of earlier discharge.

[METHODS] A retrospective review was performed of all patients who underwent unilateral DIEP flap reconstruction between January of 2021 and December of 2022 at Memorial Sloan Kettering Cancer Center. The authors assessed patient characteristics, comorbidities, and complications to identify correlations with LOS and milestone completion after implementation of an ERAS protocol.

[RESULTS] A total of 278 patients were included; the median LOS was 2.25 days (interquartile range, 2.19 to 2.33 days). Factors associated with delayed discharge included increased age, increased operative time, history of diabetes, and history of immunologic disease. Increased operative time was the only variable associated with prolonged milestone completion. A subanalysis of the safety of an earlier discharge goal of postoperative day 1 when compared with a goal of postoperative day 2 demonstrated no significant differences in complication rates.

[CONCLUSIONS] Discharge timing and milestone completion after unilateral DIEP flap reconstruction is variable and dependent on patient and operative characteristics. These insights can aid in patient optimization and may suggest ERAS protocol adjustments to enable earlier discharge for more patients. Furthermore, earlier discharge goals appear safe for appropriate patients.

[CLINICAL QUESTION/LEVEL OF EVIDENCE] Risk, III.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 diep flap 피판재건술 dict 4
해부 breast 유방 dict 2
시술 flap 피판재건술 dict 1
해부 LOS → length of stay scispacy 1
약물 [BACKGROUND] scispacy 1
약물 [RESULTS] A scispacy 1
약물 [CONCLUSIONS] Discharge scispacy 1
질환 DIEP → deep inferior epigastric artery perforator scispacy 1
질환 Cancer C0006826
Malignant Neoplasms
scispacy 1
질환 diabetes C0011847
Diabetes
scispacy 1
질환 immunologic disease C0021053
Immune System Diseases
scispacy 1
질환 LOS → length of stay scispacy 1
기타 patients scispacy 1
기타 patient scispacy 1
기타 LOS → length of stay scispacy 1

MeSH Terms

Humans; Mammaplasty; Female; Retrospective Studies; Perforator Flap; Middle Aged; Length of Stay; Patient Discharge; Epigastric Arteries; Postoperative Complications; Enhanced Recovery After Surgery; Aged; Adult; Operative Time; Ambulatory Surgical Procedures; Breast Neoplasms; Mastectomy

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문